Rank | Gene Set | Z-score |
---|---|---|
1 | synaptic vesicle exocytosis (GO:0016079) | 5.96314530 |
2 | glutamate secretion (GO:0014047) | 5.83799237 |
3 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.82792837 |
4 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.68422620 |
5 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.38845779 |
6 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.28717150 |
7 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.21877625 |
8 | vocalization behavior (GO:0071625) | 5.16610914 |
9 | protein localization to synapse (GO:0035418) | 5.11933562 |
10 | neuronal action potential propagation (GO:0019227) | 4.92050430 |
11 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.89751543 |
12 | neuron cell-cell adhesion (GO:0007158) | 4.88385629 |
13 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.78663220 |
14 | regulation of synaptic vesicle transport (GO:1902803) | 4.74088825 |
15 | synaptic vesicle maturation (GO:0016188) | 4.72136473 |
16 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.58396518 |
17 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.50336281 |
18 | behavioral response to nicotine (GO:0035095) | 4.47822231 |
19 | fucose catabolic process (GO:0019317) | 4.39958840 |
20 | L-fucose metabolic process (GO:0042354) | 4.39958840 |
21 | L-fucose catabolic process (GO:0042355) | 4.39958840 |
22 | locomotory exploration behavior (GO:0035641) | 4.38642126 |
23 | glutamate receptor signaling pathway (GO:0007215) | 4.34609742 |
24 | synaptic transmission, glutamatergic (GO:0035249) | 4.34410360 |
25 | neuron-neuron synaptic transmission (GO:0007270) | 4.33511995 |
26 | presynaptic membrane assembly (GO:0097105) | 4.32187564 |
27 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 4.31239884 |
28 | DNA deamination (GO:0045006) | 4.20872818 |
29 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.17909735 |
30 | long-term synaptic potentiation (GO:0060291) | 4.13095446 |
31 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.12966016 |
32 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.09568910 |
33 | neurotransmitter secretion (GO:0007269) | 4.04655428 |
34 | presynaptic membrane organization (GO:0097090) | 4.03197084 |
35 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.95968309 |
36 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.94747328 |
37 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.86478512 |
38 | sensory perception of smell (GO:0007608) | 3.83098700 |
39 | regulation of synaptic plasticity (GO:0048167) | 3.81183229 |
40 | behavioral response to cocaine (GO:0048148) | 3.79600847 |
41 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.77874109 |
42 | regulation of postsynaptic membrane potential (GO:0060078) | 3.74836757 |
43 | positive regulation of neurotransmitter transport (GO:0051590) | 3.74044159 |
44 | response to histamine (GO:0034776) | 3.68764274 |
45 | response to pheromone (GO:0019236) | 3.68177983 |
46 | positive regulation of synapse maturation (GO:0090129) | 3.67770303 |
47 | exploration behavior (GO:0035640) | 3.67507825 |
48 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.64869401 |
49 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.64869401 |
50 | positive regulation of membrane potential (GO:0045838) | 3.63991436 |
51 | postsynaptic membrane organization (GO:0001941) | 3.63035408 |
52 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.62404115 |
53 | synaptic vesicle endocytosis (GO:0048488) | 3.60843330 |
54 | regulation of neurotransmitter secretion (GO:0046928) | 3.59542876 |
55 | transferrin transport (GO:0033572) | 3.56404590 |
56 | neuron recognition (GO:0008038) | 3.54369797 |
57 | activation of protein kinase A activity (GO:0034199) | 3.51306453 |
58 | protein localization to cilium (GO:0061512) | 3.45289382 |
59 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.43222761 |
60 | C4-dicarboxylate transport (GO:0015740) | 3.42920582 |
61 | piRNA metabolic process (GO:0034587) | 3.42183774 |
62 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.41771149 |
63 | heart field specification (GO:0003128) | 3.41685366 |
64 | secondary heart field specification (GO:0003139) | 3.41685366 |
65 | regulation of glutamate secretion (GO:0014048) | 3.40072040 |
66 | detection of calcium ion (GO:0005513) | 3.38089044 |
67 | long-term memory (GO:0007616) | 3.37536469 |
68 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.36801515 |
69 | regulation of synapse structural plasticity (GO:0051823) | 3.35989565 |
70 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.32706751 |
71 | ferric iron transport (GO:0015682) | 3.29974693 |
72 | trivalent inorganic cation transport (GO:0072512) | 3.29974693 |
73 | preassembly of GPI anchor in ER membrane (GO:0016254) | 3.29495270 |
74 | regulation of neurotransmitter transport (GO:0051588) | 3.28709433 |
75 | proline transport (GO:0015824) | 3.28585194 |
76 | neurotransmitter transport (GO:0006836) | 3.28381774 |
77 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.28070453 |
78 | platelet dense granule organization (GO:0060155) | 3.26841459 |
79 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.26370795 |
80 | negative regulation of telomere maintenance (GO:0032205) | 3.26045212 |
81 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.25027602 |
82 | axonal fasciculation (GO:0007413) | 3.24646260 |
83 | behavioral defense response (GO:0002209) | 3.23433032 |
84 | behavioral fear response (GO:0001662) | 3.23433032 |
85 | regulation of vesicle fusion (GO:0031338) | 3.21578288 |
86 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.20051843 |
87 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.18793380 |
88 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.18793380 |
89 | NADH dehydrogenase complex assembly (GO:0010257) | 3.18793380 |
90 | long term synaptic depression (GO:0060292) | 3.16684896 |
91 | membrane depolarization (GO:0051899) | 3.16672944 |
92 | chaperone-mediated protein transport (GO:0072321) | 3.13804254 |
93 | cerebellar granule cell differentiation (GO:0021707) | 3.12984718 |
94 | positive regulation of synaptic transmission (GO:0050806) | 3.12362935 |
95 | fear response (GO:0042596) | 3.10885086 |
96 | protein complex biogenesis (GO:0070271) | 3.08487334 |
97 | regulation of synaptic transmission (GO:0050804) | 3.08454916 |
98 | synaptic transmission (GO:0007268) | 3.07866104 |
99 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.07099744 |
100 | mechanosensory behavior (GO:0007638) | 3.04930619 |
101 | gamma-aminobutyric acid transport (GO:0015812) | 3.04490670 |
102 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.04075580 |
103 | primary amino compound metabolic process (GO:1901160) | 3.03510091 |
104 | cellular potassium ion homeostasis (GO:0030007) | 3.03026218 |
105 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.02919596 |
106 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.02407840 |
107 | female mating behavior (GO:0060180) | 3.02279905 |
108 | regulation of dendritic spine development (GO:0060998) | 3.01726547 |
109 | regulation of neurotransmitter levels (GO:0001505) | 3.00043436 |
110 | protein K11-linked deubiquitination (GO:0035871) | 2.99917862 |
111 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.98028065 |
112 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.95830317 |
113 | termination of RNA polymerase III transcription (GO:0006386) | 2.95830317 |
114 | membrane depolarization during action potential (GO:0086010) | 2.95564502 |
115 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.95469461 |
116 | regulation of synapse maturation (GO:0090128) | 2.94560834 |
117 | regulation of mesoderm development (GO:2000380) | 2.94149932 |
118 | negative regulation of dendrite development (GO:2000171) | 2.93531872 |
119 | regulation of female receptivity (GO:0045924) | 2.92967487 |
120 | serotonin metabolic process (GO:0042428) | 2.92914592 |
121 | dendritic spine morphogenesis (GO:0060997) | 2.92538122 |
122 | startle response (GO:0001964) | 2.92261372 |
123 | synaptic vesicle transport (GO:0048489) | 2.91924993 |
124 | establishment of synaptic vesicle localization (GO:0097480) | 2.91924993 |
125 | layer formation in cerebral cortex (GO:0021819) | 2.90960769 |
126 | learning (GO:0007612) | 2.89696055 |
127 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.89653982 |
128 | transmission of nerve impulse (GO:0019226) | 2.89571279 |
129 | cellular response to ATP (GO:0071318) | 2.89541617 |
130 | calcium ion-dependent exocytosis (GO:0017156) | 2.89012450 |
131 | pseudouridine synthesis (GO:0001522) | 2.84790589 |
132 | protein deneddylation (GO:0000338) | 2.80787580 |
133 | somite rostral/caudal axis specification (GO:0032525) | 2.80413160 |
134 | sleep (GO:0030431) | 2.79000797 |
135 | protein-cofactor linkage (GO:0018065) | 2.78506329 |
136 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.77459157 |
137 | cullin deneddylation (GO:0010388) | 2.77086799 |
138 | sulfation (GO:0051923) | 2.75054571 |
139 | intracellular protein transmembrane import (GO:0044743) | 2.71002403 |
140 | adaptation of signaling pathway (GO:0023058) | 2.69102473 |
141 | axon ensheathment in central nervous system (GO:0032291) | 2.67642021 |
142 | central nervous system myelination (GO:0022010) | 2.67642021 |
143 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.67161391 |
144 | DNA methylation involved in gamete generation (GO:0043046) | 2.60642256 |
145 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.52414124 |
146 | detection of light stimulus involved in visual perception (GO:0050908) | 2.52414124 |
147 | ubiquinone biosynthetic process (GO:0006744) | 2.50833163 |
148 | respiratory chain complex IV assembly (GO:0008535) | 2.49849491 |
149 | detection of mechanical stimulus involved in sensory perception (GO:0050974) | 2.46869550 |
150 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.44806380 |
151 | ATP synthesis coupled proton transport (GO:0015986) | 2.44806380 |
152 | cell migration involved in gastrulation (GO:0042074) | 2.42817290 |
153 | auditory receptor cell stereocilium organization (GO:0060088) | 2.42127909 |
154 | retinal cone cell development (GO:0046549) | 2.41999839 |
155 | neuronal action potential (GO:0019228) | 2.41676767 |
156 | reflex (GO:0060004) | 2.41528403 |
157 | serotonin receptor signaling pathway (GO:0007210) | 2.40167444 |
158 | cardiac ventricle formation (GO:0003211) | 2.39245692 |
159 | nucleotide transmembrane transport (GO:1901679) | 2.38335409 |
160 | glycerophospholipid catabolic process (GO:0046475) | 2.37358552 |
161 | cellular anion homeostasis (GO:0030002) | 2.36776811 |
162 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 2.36416937 |
163 | adult feeding behavior (GO:0008343) | 2.35700576 |
164 | phosphorelay signal transduction system (GO:0000160) | 2.35376087 |
165 | regulation of sensory perception of pain (GO:0051930) | 2.34842151 |
166 | regulation of sensory perception (GO:0051931) | 2.34842151 |
167 | mannosylation (GO:0097502) | 2.32068379 |
168 | glycosphingolipid biosynthetic process (GO:0006688) | 2.31224349 |
169 | male meiosis I (GO:0007141) | 2.31199482 |
170 | positive regulation of cell fate commitment (GO:0010455) | 2.30989030 |
171 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.30534094 |
172 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.30534094 |
173 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 2.30172265 |
174 | ubiquinone metabolic process (GO:0006743) | 2.29620249 |
175 | electron transport chain (GO:0022900) | 2.29424863 |
176 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 2.28880976 |
177 | dopamine transport (GO:0015872) | 2.28725005 |
178 | rhodopsin mediated signaling pathway (GO:0016056) | 2.27224237 |
179 | kynurenine metabolic process (GO:0070189) | 2.26276742 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.31339107 |
2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.54700430 |
3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.17881329 |
4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.03697100 |
5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.01966603 |
6 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.74480410 |
7 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.72182951 |
8 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.63488476 |
9 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.63488476 |
10 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.62836849 |
11 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.56519879 |
12 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.53615914 |
13 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.49807997 |
14 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.47920617 |
15 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.44770140 |
16 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.42353589 |
17 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.40573018 |
18 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.40533083 |
19 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.29356835 |
20 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.23616965 |
21 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.23408142 |
22 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.20020089 |
23 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.19361971 |
24 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.19130647 |
25 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.12415585 |
26 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.12218765 |
27 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.08677193 |
28 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.08562036 |
29 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.05935045 |
30 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.00835091 |
31 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.98072049 |
32 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.97697310 |
33 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.89412350 |
34 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.89161852 |
35 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.88720642 |
36 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.84902554 |
37 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.82834351 |
38 | P300_19829295_ChIP-Seq_ESCs_Human | 1.79771594 |
39 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.76891288 |
40 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.71366202 |
41 | VDR_22108803_ChIP-Seq_LS180_Human | 1.70239793 |
42 | EWS_26573619_Chip-Seq_HEK293_Human | 1.67821415 |
43 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.67603177 |
44 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.64179969 |
45 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.62163064 |
46 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.60717933 |
47 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.60190680 |
48 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.60169097 |
49 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.57942056 |
50 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.55453017 |
51 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.55335803 |
52 | FUS_26573619_Chip-Seq_HEK293_Human | 1.54576970 |
53 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.52512573 |
54 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.52115639 |
55 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.51775989 |
56 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.51074982 |
57 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.50172817 |
58 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.48174917 |
59 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.48110759 |
60 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.47948479 |
61 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.45965945 |
62 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.38836183 |
63 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.38494713 |
64 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.35815281 |
65 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.34770534 |
66 | AR_25329375_ChIP-Seq_VCAP_Human | 1.34322418 |
67 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.33945146 |
68 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.33049026 |
69 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.31805416 |
70 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.31540923 |
71 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.29984126 |
72 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.29259752 |
73 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.28888643 |
74 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.28888643 |
75 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.28717709 |
76 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.26941289 |
77 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.26457994 |
78 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.26160768 |
79 | STAT3_23295773_ChIP-Seq_U87_Human | 1.22789747 |
80 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.22115653 |
81 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.21648885 |
82 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.20303986 |
83 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.19840439 |
84 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.19193995 |
85 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.18498679 |
86 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.17953097 |
87 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.17953097 |
88 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.17210606 |
89 | TCF4_23295773_ChIP-Seq_U87_Human | 1.17039876 |
90 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.15377808 |
91 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.15237169 |
92 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.14767422 |
93 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.13964649 |
94 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.13741948 |
95 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.13594078 |
96 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.12946248 |
97 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.11178879 |
98 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.10507728 |
99 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.10507728 |
100 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.09962070 |
101 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.09960506 |
102 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.09820537 |
103 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.09474146 |
104 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.09221873 |
105 | JUN_21703547_ChIP-Seq_K562_Human | 1.08950899 |
106 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.08731091 |
107 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.07692848 |
108 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.07541279 |
109 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.07418145 |
110 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.07073824 |
111 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.06938047 |
112 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.06801677 |
113 | AR_19668381_ChIP-Seq_PC3_Human | 1.06046260 |
114 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.05935075 |
115 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.04399346 |
116 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.02893076 |
117 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.01875657 |
118 | NCOR_22424771_ChIP-Seq_293T_Human | 1.00752813 |
119 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.00706115 |
120 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00703210 |
121 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.00613851 |
122 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00613851 |
123 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.00459252 |
124 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.00431895 |
125 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.00367480 |
126 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.00210107 |
127 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.98067118 |
128 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.97131933 |
129 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.96785400 |
130 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.96275689 |
131 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.96250394 |
132 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.95776265 |
133 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.95294576 |
134 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.94727063 |
135 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.93925342 |
136 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.92655818 |
137 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.92343296 |
138 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.91857569 |
139 | KDM2B_26808549_Chip-Seq_REH_Human | 0.90847328 |
140 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.88117226 |
141 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.87123138 |
142 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.86350028 |
143 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.86348345 |
144 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.86342728 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004859_abnormal_synaptic_plasticity | 6.25060174 |
2 | MP0003880_abnormal_central_pattern | 5.77700025 |
3 | MP0003635_abnormal_synaptic_transmissio | 4.13349549 |
4 | MP0001984_abnormal_olfaction | 3.68662572 |
5 | MP0004270_analgesia | 3.65292831 |
6 | MP0009745_abnormal_behavioral_response | 3.48445994 |
7 | MP0002063_abnormal_learning/memory/cond | 3.36322497 |
8 | MP0001968_abnormal_touch/_nociception | 3.32553986 |
9 | MP0002064_seizures | 3.30205674 |
10 | MP0009046_muscle_twitch | 3.09570999 |
11 | MP0002234_abnormal_pharynx_morphology | 3.00780172 |
12 | MP0002572_abnormal_emotion/affect_behav | 2.97423305 |
13 | MP0002736_abnormal_nociception_after | 2.93057019 |
14 | MP0002272_abnormal_nervous_system | 2.75430148 |
15 | MP0002734_abnormal_mechanical_nocicepti | 2.57918743 |
16 | MP0001486_abnormal_startle_reflex | 2.50513856 |
17 | MP0001501_abnormal_sleep_pattern | 2.38167664 |
18 | MP0002822_catalepsy | 2.33081844 |
19 | MP0001986_abnormal_taste_sensitivity | 2.32243900 |
20 | MP0001440_abnormal_grooming_behavior | 2.28654303 |
21 | MP0002735_abnormal_chemical_nociception | 2.26658073 |
22 | MP0008875_abnormal_xenobiotic_pharmacok | 2.12002915 |
23 | MP0002067_abnormal_sensory_capabilities | 2.06831060 |
24 | MP0003879_abnormal_hair_cell | 1.94570667 |
25 | MP0009780_abnormal_chondrocyte_physiolo | 1.91602756 |
26 | MP0001970_abnormal_pain_threshold | 1.89445147 |
27 | MP0002733_abnormal_thermal_nociception | 1.81973807 |
28 | MP0006072_abnormal_retinal_apoptosis | 1.79626405 |
29 | MP0002184_abnormal_innervation | 1.78625492 |
30 | MP0002837_dystrophic_cardiac_calcinosis | 1.75202142 |
31 | MP0003329_amyloid_beta_deposits | 1.75195267 |
32 | MP0005646_abnormal_pituitary_gland | 1.74100154 |
33 | MP0002102_abnormal_ear_morphology | 1.73676672 |
34 | MP0005423_abnormal_somatic_nervous | 1.70765222 |
35 | MP0004924_abnormal_behavior | 1.69104851 |
36 | MP0005386_behavior/neurological_phenoty | 1.69104851 |
37 | MP0001529_abnormal_vocalization | 1.67819225 |
38 | MP0004147_increased_porphyrin_level | 1.67438192 |
39 | MP0002557_abnormal_social/conspecific_i | 1.66714788 |
40 | MP0000778_abnormal_nervous_system | 1.65861902 |
41 | MP0008569_lethality_at_weaning | 1.65040722 |
42 | MP0006292_abnormal_olfactory_placode | 1.62119932 |
43 | MP0004811_abnormal_neuron_physiology | 1.59423228 |
44 | MP0003787_abnormal_imprinting | 1.58892042 |
45 | MP0005253_abnormal_eye_physiology | 1.53978343 |
46 | MP0002160_abnormal_reproductive_system | 1.53288302 |
47 | MP0006276_abnormal_autonomic_nervous | 1.50107771 |
48 | MP0000427_abnormal_hair_cycle | 1.47450284 |
49 | MP0001905_abnormal_dopamine_level | 1.42831292 |
50 | MP0002638_abnormal_pupillary_reflex | 1.42801911 |
51 | MP0002909_abnormal_adrenal_gland | 1.41717092 |
52 | MP0002876_abnormal_thyroid_physiology | 1.39352320 |
53 | MP0000569_abnormal_digit_pigmentation | 1.38445537 |
54 | MP0003195_calcinosis | 1.36938319 |
55 | MP0002066_abnormal_motor_capabilities/c | 1.35720935 |
56 | MP0001188_hyperpigmentation | 1.34310733 |
57 | MP0002882_abnormal_neuron_morphology | 1.34250962 |
58 | MP0005389_reproductive_system_phenotype | 1.32877067 |
59 | MP0001919_abnormal_reproductive_system | 1.29673333 |
60 | MP0000955_abnormal_spinal_cord | 1.29344052 |
61 | MP0004858_abnormal_nervous_system | 1.23085742 |
62 | MP0003633_abnormal_nervous_system | 1.20926827 |
63 | MP0002163_abnormal_gland_morphology | 1.20502542 |
64 | MP0004142_abnormal_muscle_tone | 1.18769238 |
65 | MP0003136_yellow_coat_color | 1.18206238 |
66 | MP0001502_abnormal_circadian_rhythm | 1.17939988 |
67 | MP0005379_endocrine/exocrine_gland_phen | 1.14827044 |
68 | MP0003122_maternal_imprinting | 1.10858262 |
69 | MP0001485_abnormal_pinna_reflex | 1.10022550 |
70 | MP0000013_abnormal_adipose_tissue | 1.09733274 |
71 | MP0005394_taste/olfaction_phenotype | 1.04932711 |
72 | MP0005499_abnormal_olfactory_system | 1.04932711 |
73 | MP0000751_myopathy | 1.04809812 |
74 | MP0002938_white_spotting | 1.04738774 |
75 | MP0005645_abnormal_hypothalamus_physiol | 1.03372453 |
76 | MP0003631_nervous_system_phenotype | 1.03343624 |
77 | MP0010386_abnormal_urinary_bladder | 1.01920546 |
78 | MP0002152_abnormal_brain_morphology | 1.01501254 |
79 | MP0003718_maternal_effect | 1.01042689 |
80 | MP0001963_abnormal_hearing_physiology | 0.98568450 |
81 | MP0008874_decreased_physiological_sensi | 0.98060871 |
82 | MP0002751_abnormal_autonomic_nervous | 0.97314521 |
83 | MP0008872_abnormal_physiological_respon | 0.97080097 |
84 | MP0002229_neurodegeneration | 0.93140978 |
85 | MP0004145_abnormal_muscle_electrophysio | 0.91514607 |
86 | MP0008058_abnormal_DNA_repair | 0.91024852 |
87 | MP0005195_abnormal_posterior_eye | 0.90255080 |
88 | MP0002069_abnormal_eating/drinking_beha | 0.87859417 |
89 | MP0004484_altered_response_of | 0.87851009 |
90 | MP0005551_abnormal_eye_electrophysiolog | 0.86215691 |
91 | MP0005535_abnormal_body_temperature | 0.85385619 |
92 | MP0001664_abnormal_digestion | 0.85191564 |
93 | MP0002210_abnormal_sex_determination | 0.84543687 |
94 | MP0004742_abnormal_vestibular_system | 0.84087534 |
95 | MP0003698_abnormal_male_reproductive | 0.83469397 |
96 | MP0004215_abnormal_myocardial_fiber | 0.81990739 |
97 | MP0004133_heterotaxia | 0.81982218 |
98 | MP0000647_abnormal_sebaceous_gland | 0.81371187 |
99 | MP0004885_abnormal_endolymph | 0.81317431 |
100 | MP0008004_abnormal_stomach_pH | 0.77724413 |
101 | MP0002752_abnormal_somatic_nervous | 0.77609775 |
102 | MP0004085_abnormal_heartbeat | 0.76575713 |
103 | MP0000604_amyloidosis | 0.75557492 |
104 | MP0008775_abnormal_heart_ventricle | 0.74641572 |
105 | MP0001873_stomach_inflammation | 0.73782223 |
106 | MP0000631_abnormal_neuroendocrine_gland | 0.73033615 |
107 | MP0003137_abnormal_impulse_conducting | 0.72423826 |
108 | MP0001929_abnormal_gametogenesis | 0.70481572 |
109 | MP0006036_abnormal_mitochondrial_physio | 0.69309466 |
110 | MP0002693_abnormal_pancreas_physiology | 0.68826906 |
111 | MP0005174_abnormal_tail_pigmentation | 0.68434475 |
112 | MP0003936_abnormal_reproductive_system | 0.65219483 |
113 | MP0001177_atelectasis | 0.64881195 |
114 | MP0003646_muscle_fatigue | 0.63712063 |
115 | MP0003632_abnormal_nervous_system | 0.63080718 |
116 | MP0000026_abnormal_inner_ear | 0.60504271 |
117 | MP0003634_abnormal_glial_cell | 0.59707502 |
118 | MP0003183_abnormal_peptide_metabolism | 0.58428634 |
119 | MP0003075_altered_response_to | 0.57833241 |
120 | MP0004510_myositis | 0.57654081 |
121 | MP0002653_abnormal_ependyma_morphology | 0.56880556 |
122 | MP0010234_abnormal_vibrissa_follicle | 0.56787331 |
123 | MP0001765_abnormal_ion_homeostasis | 0.56635163 |
124 | MP0005171_absent_coat_pigmentation | 0.56501829 |
125 | MP0008877_abnormal_DNA_methylation | 0.53776604 |
126 | MP0005084_abnormal_gallbladder_morpholo | 0.53744634 |
127 | MP0004043_abnormal_pH_regulation | 0.52846235 |
128 | MP0001943_abnormal_respiration | 0.50984759 |
129 | MP0006035_abnormal_mitochondrial_morpho | 0.48700739 |
130 | MP0000920_abnormal_myelination | 0.48435769 |
131 | MP0003956_abnormal_body_size | 0.48296232 |
132 | MP0005410_abnormal_fertilization | 0.48067942 |
133 | MP0010770_preweaning_lethality | 0.47101662 |
134 | MP0002082_postnatal_lethality | 0.47101662 |
135 | MP0008789_abnormal_olfactory_epithelium | 0.46989735 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Focal motor seizures (HP:0011153) | 8.69587758 |
2 | Atonic seizures (HP:0010819) | 6.18164797 |
3 | Myokymia (HP:0002411) | 6.14334189 |
4 | Focal seizures (HP:0007359) | 5.73109248 |
5 | Epileptic encephalopathy (HP:0200134) | 5.72695222 |
6 | Febrile seizures (HP:0002373) | 5.34211070 |
7 | Hyperventilation (HP:0002883) | 4.97826368 |
8 | Absence seizures (HP:0002121) | 4.74415629 |
9 | Visual hallucinations (HP:0002367) | 4.71053966 |
10 | Type II lissencephaly (HP:0007260) | 4.53310642 |
11 | Dialeptic seizures (HP:0011146) | 4.32601862 |
12 | Generalized tonic-clonic seizures (HP:0002069) | 3.93994363 |
13 | Progressive cerebellar ataxia (HP:0002073) | 3.86359712 |
14 | Broad-based gait (HP:0002136) | 3.58692723 |
15 | Amblyopia (HP:0000646) | 3.55493587 |
16 | Gaze-evoked nystagmus (HP:0000640) | 3.38087851 |
17 | Molar tooth sign on MRI (HP:0002419) | 3.34893162 |
18 | Abnormality of midbrain morphology (HP:0002418) | 3.34893162 |
19 | Pancreatic cysts (HP:0001737) | 3.34530548 |
20 | Abnormality of alanine metabolism (HP:0010916) | 3.24969760 |
21 | Hyperalaninemia (HP:0003348) | 3.24969760 |
22 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 3.24969760 |
23 | Poor eye contact (HP:0000817) | 3.08503438 |
24 | Congenital stationary night blindness (HP:0007642) | 3.08452081 |
25 | Pancreatic fibrosis (HP:0100732) | 3.06834703 |
26 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.04331230 |
27 | True hermaphroditism (HP:0010459) | 2.96588236 |
28 | Epileptiform EEG discharges (HP:0011182) | 2.87357503 |
29 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.87082679 |
30 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.87082679 |
31 | Truncal ataxia (HP:0002078) | 2.86761642 |
32 | Anterior segment dysgenesis (HP:0007700) | 2.86597918 |
33 | Acute necrotizing encephalopathy (HP:0006965) | 2.85507482 |
34 | Gait imbalance (HP:0002141) | 2.84641789 |
35 | Anxiety (HP:0000739) | 2.82211677 |
36 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.81672333 |
37 | Nephronophthisis (HP:0000090) | 2.80629833 |
38 | Cerebellar dysplasia (HP:0007033) | 2.75973010 |
39 | Dysmetria (HP:0001310) | 2.74589966 |
40 | Dysdiadochokinesis (HP:0002075) | 2.74086144 |
41 | Neuroendocrine neoplasm (HP:0100634) | 2.72654158 |
42 | Pheochromocytoma (HP:0002666) | 2.71846116 |
43 | Abnormal eating behavior (HP:0100738) | 2.71798323 |
44 | Impaired social interactions (HP:0000735) | 2.71211874 |
45 | Abnormal social behavior (HP:0012433) | 2.71211874 |
46 | Action tremor (HP:0002345) | 2.71020111 |
47 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.69248990 |
48 | Depression (HP:0000716) | 2.68650262 |
49 | Congenital primary aphakia (HP:0007707) | 2.65982511 |
50 | Medial flaring of the eyebrow (HP:0010747) | 2.62092863 |
51 | Progressive macrocephaly (HP:0004481) | 2.60670979 |
52 | Birth length less than 3rd percentile (HP:0003561) | 2.60334721 |
53 | Drooling (HP:0002307) | 2.55105126 |
54 | Excessive salivation (HP:0003781) | 2.55105126 |
55 | Pendular nystagmus (HP:0012043) | 2.53638771 |
56 | Supranuclear gaze palsy (HP:0000605) | 2.52954624 |
57 | Impaired smooth pursuit (HP:0007772) | 2.52067763 |
58 | EEG with generalized epileptiform discharges (HP:0011198) | 2.51874353 |
59 | Retinal dysplasia (HP:0007973) | 2.50331019 |
60 | Inability to walk (HP:0002540) | 2.49041461 |
61 | Termporal pattern (HP:0011008) | 2.49005000 |
62 | Insidious onset (HP:0003587) | 2.49005000 |
63 | Scanning speech (HP:0002168) | 2.47720789 |
64 | Nephrogenic diabetes insipidus (HP:0009806) | 2.47267023 |
65 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.46519422 |
66 | Congenital, generalized hypertrichosis (HP:0004540) | 2.45786943 |
67 | Keratoconus (HP:0000563) | 2.44795088 |
68 | Increased corneal curvature (HP:0100692) | 2.44795088 |
69 | Delusions (HP:0000746) | 2.42963774 |
70 | Abnormality of the renal cortex (HP:0011035) | 2.40536478 |
71 | Abolished electroretinogram (ERG) (HP:0000550) | 2.35771212 |
72 | Abnormality of the renal medulla (HP:0100957) | 2.34751907 |
73 | Abnormal hair whorl (HP:0010721) | 2.34023746 |
74 | Protruding tongue (HP:0010808) | 2.33652278 |
75 | Abnormality of binocular vision (HP:0011514) | 2.33517210 |
76 | Diplopia (HP:0000651) | 2.33517210 |
77 | Lissencephaly (HP:0001339) | 2.33430443 |
78 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.31780414 |
79 | Absent speech (HP:0001344) | 2.31775102 |
80 | Hypsarrhythmia (HP:0002521) | 2.31726820 |
81 | Cerebral hypomyelination (HP:0006808) | 2.29972260 |
82 | Dysmetric saccades (HP:0000641) | 2.29925102 |
83 | Cerebral inclusion bodies (HP:0100314) | 2.28992191 |
84 | Large for gestational age (HP:0001520) | 2.28665410 |
85 | Focal dystonia (HP:0004373) | 2.25189807 |
86 | Torticollis (HP:0000473) | 2.23702192 |
87 | Mitochondrial inheritance (HP:0001427) | 2.20920395 |
88 | Impaired vibratory sensation (HP:0002495) | 2.20542107 |
89 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.19719769 |
90 | Absent/shortened dynein arms (HP:0200106) | 2.19719769 |
91 | Abnormality of the lower motor neuron (HP:0002366) | 2.19194582 |
92 | Optic disc pallor (HP:0000543) | 2.19139431 |
93 | Acute encephalopathy (HP:0006846) | 2.17790041 |
94 | Genetic anticipation (HP:0003743) | 2.16251516 |
95 | Sclerocornea (HP:0000647) | 2.15956241 |
96 | Bradykinesia (HP:0002067) | 2.15715864 |
97 | Resting tremor (HP:0002322) | 2.15501825 |
98 | Stereotypic behavior (HP:0000733) | 2.15048868 |
99 | Attenuation of retinal blood vessels (HP:0007843) | 2.14203355 |
100 | Progressive inability to walk (HP:0002505) | 2.13502358 |
101 | 3-Methylglutaconic aciduria (HP:0003535) | 2.13240473 |
102 | Limb dystonia (HP:0002451) | 2.12391271 |
103 | Status epilepticus (HP:0002133) | 2.11579110 |
104 | Specific learning disability (HP:0001328) | 2.10911476 |
105 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.10684662 |
106 | Urinary urgency (HP:0000012) | 2.10512767 |
107 | Generalized myoclonic seizures (HP:0002123) | 2.09779911 |
108 | Ankle clonus (HP:0011448) | 2.09480293 |
109 | Hemiparesis (HP:0001269) | 2.08887103 |
110 | Autoimmune thrombocytopenia (HP:0001973) | 2.08477454 |
111 | Hypomagnesemia (HP:0002917) | 2.07753095 |
112 | Postural instability (HP:0002172) | 2.06755097 |
113 | Tubular atrophy (HP:0000092) | 2.06597442 |
114 | Sensory axonal neuropathy (HP:0003390) | 2.06346484 |
115 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.06136142 |
116 | Severe muscular hypotonia (HP:0006829) | 2.06010457 |
117 | Hypokalemic alkalosis (HP:0001949) | 2.01770499 |
118 | Polyphagia (HP:0002591) | 2.00119094 |
119 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.99998308 |
120 | Craniofacial dystonia (HP:0012179) | 1.98528309 |
121 | Spastic gait (HP:0002064) | 1.98473344 |
122 | Decreased circulating renin level (HP:0003351) | 1.98409811 |
123 | Abnormal ciliary motility (HP:0012262) | 1.98212095 |
124 | Cystic liver disease (HP:0006706) | 1.97236911 |
125 | Pachygyria (HP:0001302) | 1.96933813 |
126 | Increased serum lactate (HP:0002151) | 1.96561691 |
127 | Incomplete penetrance (HP:0003829) | 1.96138401 |
128 | Vaginal atresia (HP:0000148) | 1.95781117 |
129 | Blue irides (HP:0000635) | 1.94962658 |
130 | Genital tract atresia (HP:0001827) | 1.94262111 |
131 | Abnormality of the labia minora (HP:0012880) | 1.93272657 |
132 | Poor coordination (HP:0002370) | 1.93203917 |
133 | Methylmalonic acidemia (HP:0002912) | 1.92988712 |
134 | Increased CSF lactate (HP:0002490) | 1.91334927 |
135 | Fetal akinesia sequence (HP:0001989) | 1.90765395 |
136 | Lactic acidosis (HP:0003128) | 1.90407839 |
137 | Progressive microcephaly (HP:0000253) | 1.90232160 |
138 | Hepatocellular necrosis (HP:0001404) | 1.88508320 |
139 | Prominent supraorbital ridges (HP:0000336) | 1.88416883 |
140 | Abnormality of the pons (HP:0007361) | 1.88215077 |
141 | Rhinitis (HP:0012384) | 1.87697874 |
142 | Hydroureter (HP:0000072) | 1.86552718 |
143 | Polydipsia (HP:0001959) | 1.85992898 |
144 | Abnormal drinking behavior (HP:0030082) | 1.85992898 |
145 | Furrowed tongue (HP:0000221) | 1.84647881 |
146 | Gait ataxia (HP:0002066) | 1.84410097 |
147 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.84282541 |
148 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.84282541 |
149 | Hypoplasia of the uterus (HP:0000013) | 1.83255618 |
150 | Abnormality of the corticospinal tract (HP:0002492) | 1.82898221 |
151 | Abnormality of magnesium homeostasis (HP:0004921) | 1.82283086 |
152 | Hypoplasia of the pons (HP:0012110) | 1.81762432 |
153 | Abnormality of salivation (HP:0100755) | 1.80052189 |
154 | Abnormal gallbladder physiology (HP:0012438) | 1.78826093 |
155 | Hepatic necrosis (HP:0002605) | 1.77549342 |
156 | Cerebral edema (HP:0002181) | 1.76967910 |
157 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.76821513 |
158 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.75158391 |
159 | Horizontal nystagmus (HP:0000666) | 1.74738936 |
160 | Methylmalonic aciduria (HP:0012120) | 1.72343918 |
161 | Respiratory failure (HP:0002878) | 1.72033785 |
162 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.71733399 |
163 | Chronic hepatic failure (HP:0100626) | 1.71506978 |
164 | Polyuria (HP:0000103) | 1.71466852 |
165 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.71460706 |
166 | Leukodystrophy (HP:0002415) | 1.71168585 |
167 | CNS hypomyelination (HP:0003429) | 1.69403197 |
168 | Myotonia (HP:0002486) | 1.66449390 |
169 | Thyroid-stimulating hormone excess (HP:0002925) | 1.65459327 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EPHA4 | 4.86696908 |
2 | NTRK3 | 4.05889715 |
3 | CASK | 3.85445753 |
4 | TLK1 | 3.63120463 |
5 | FRK | 3.55405231 |
6 | MAP3K4 | 3.28740333 |
7 | MAP3K12 | 3.28187027 |
8 | DAPK2 | 3.20031093 |
9 | MAP2K7 | 3.19796698 |
10 | RIPK4 | 3.10164302 |
11 | PIK3CA | 3.09494612 |
12 | MAP3K9 | 3.07435286 |
13 | CDK19 | 2.64314940 |
14 | DAPK1 | 2.56628748 |
15 | PLK2 | 2.40169527 |
16 | ADRBK2 | 2.38789918 |
17 | TIE1 | 2.09656788 |
18 | MAP2K4 | 2.07642466 |
19 | ARAF | 2.03712357 |
20 | MAP4K2 | 2.03486668 |
21 | MINK1 | 2.01878561 |
22 | GRK1 | 1.94604430 |
23 | INSRR | 1.90927403 |
24 | STK39 | 1.80950017 |
25 | ZAK | 1.80312796 |
26 | BMPR2 | 1.73619426 |
27 | CCNB1 | 1.67182077 |
28 | GRK5 | 1.66352973 |
29 | BMPR1B | 1.66192886 |
30 | WNK4 | 1.65887347 |
31 | PNCK | 1.60246383 |
32 | WNK3 | 1.58194414 |
33 | LIMK1 | 1.57798387 |
34 | OXSR1 | 1.51899041 |
35 | KSR2 | 1.45461131 |
36 | PAK6 | 1.42547848 |
37 | KSR1 | 1.40940147 |
38 | PTK2B | 1.37809235 |
39 | PRPF4B | 1.37575595 |
40 | AKT3 | 1.36403556 |
41 | MARK1 | 1.34098434 |
42 | PRKCG | 1.29840714 |
43 | CDK5 | 1.28057921 |
44 | NME1 | 1.25170098 |
45 | CAMK2B | 1.25131900 |
46 | MAP3K13 | 1.24339471 |
47 | NTRK2 | 1.22309583 |
48 | NUAK1 | 1.16090420 |
49 | PRKD3 | 1.15265685 |
50 | CAMK2A | 1.13631430 |
51 | CAMKK1 | 1.13571210 |
52 | CAMKK2 | 1.09739193 |
53 | TNIK | 1.09521923 |
54 | TRIM28 | 1.08637211 |
55 | MAPK13 | 1.04657785 |
56 | PLK3 | 0.98514875 |
57 | MAP2K6 | 0.97007479 |
58 | CSNK1G3 | 0.93572471 |
59 | CSNK1G1 | 0.93157251 |
60 | BRAF | 0.92380348 |
61 | NTRK1 | 0.90822137 |
62 | FES | 0.90238674 |
63 | BUB1 | 0.89048068 |
64 | MST4 | 0.88922928 |
65 | RAF1 | 0.84384713 |
66 | STK38 | 0.84089278 |
67 | CAMK1G | 0.82660392 |
68 | SGK223 | 0.82376172 |
69 | SGK494 | 0.82376172 |
70 | VRK1 | 0.81849041 |
71 | ACVR1B | 0.81060111 |
72 | DAPK3 | 0.80309061 |
73 | STK38L | 0.78848107 |
74 | MAP3K2 | 0.78595061 |
75 | PDK3 | 0.76924216 |
76 | PDK4 | 0.76924216 |
77 | CSNK1A1L | 0.75432457 |
78 | CDK18 | 0.74993136 |
79 | SIK2 | 0.74724563 |
80 | CAMK2D | 0.73371130 |
81 | CAMK1D | 0.73065913 |
82 | STK16 | 0.73025320 |
83 | FGR | 0.71527178 |
84 | SGK2 | 0.71334959 |
85 | TSSK6 | 0.71160981 |
86 | CDK14 | 0.70195503 |
87 | PRKCI | 0.70066580 |
88 | CDK15 | 0.69666990 |
89 | CAMK1 | 0.68046653 |
90 | CAMK2G | 0.66889618 |
91 | UHMK1 | 0.65388550 |
92 | TAF1 | 0.63343313 |
93 | STK11 | 0.61013514 |
94 | CDK11A | 0.59587510 |
95 | VRK2 | 0.58529256 |
96 | PRKCE | 0.58498400 |
97 | EIF2AK3 | 0.58465631 |
98 | SIK3 | 0.58155458 |
99 | SGK1 | 0.57608510 |
100 | PDK1 | 0.57386655 |
101 | PDPK1 | 0.56669754 |
102 | DYRK1A | 0.56100065 |
103 | CSNK1G2 | 0.56045283 |
104 | TYRO3 | 0.54533514 |
105 | PAK3 | 0.54315771 |
106 | GRK6 | 0.52765043 |
107 | MKNK2 | 0.52040728 |
108 | DYRK2 | 0.50588569 |
109 | FER | 0.50121659 |
110 | MET | 0.48990351 |
111 | PHKG1 | 0.48258396 |
112 | PHKG2 | 0.48258396 |
113 | MAP3K6 | 0.47411308 |
114 | BCR | 0.46992969 |
115 | PLK1 | 0.45577158 |
116 | WEE1 | 0.44711487 |
117 | MYLK | 0.44229162 |
118 | CSNK1A1 | 0.43475796 |
119 | ERBB3 | 0.43398631 |
120 | MAPKAPK3 | 0.42413896 |
121 | TNK2 | 0.41816935 |
122 | SGK3 | 0.41405811 |
123 | TXK | 0.40913164 |
124 | PRKCA | 0.40487135 |
125 | PRKCH | 0.39408530 |
126 | MAP2K1 | 0.38767495 |
127 | IRAK1 | 0.38561362 |
128 | ADRBK1 | 0.38536872 |
129 | BCKDK | 0.37970483 |
130 | MAP3K1 | 0.37895694 |
131 | LATS1 | 0.37530350 |
132 | RET | 0.36912257 |
133 | PRKCZ | 0.36392370 |
134 | ROCK2 | 0.36155919 |
135 | PINK1 | 0.35858941 |
136 | FLT3 | 0.35628270 |
137 | TAOK3 | 0.35590039 |
138 | MAPK12 | 0.35435443 |
139 | MARK2 | 0.35368385 |
140 | PDK2 | 0.33820122 |
141 | GRK7 | 0.33320943 |
142 | CSNK1D | 0.33242778 |
143 | MAP3K7 | 0.32294730 |
144 | NEK1 | 0.31727715 |
145 | MAPK7 | 0.31713869 |
146 | PRKG1 | 0.31285872 |
147 | PRKACA | 0.31058003 |
148 | MOS | 0.30788191 |
149 | TAOK1 | 0.30742482 |
150 | RPS6KA3 | 0.30050113 |
151 | CAMK4 | 0.29182115 |
152 | TGFBR1 | 0.29055858 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Olfactory transduction_Homo sapiens_hsa04740 | 3.85602889 |
2 | Nicotine addiction_Homo sapiens_hsa05033 | 3.80046499 |
3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.74434632 |
4 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.95731006 |
5 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.80928696 |
6 | Long-term potentiation_Homo sapiens_hsa04720 | 2.73551467 |
7 | Circadian entrainment_Homo sapiens_hsa04713 | 2.68937132 |
8 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.54238496 |
9 | Morphine addiction_Homo sapiens_hsa05032 | 2.53144676 |
10 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.51002217 |
11 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.45629231 |
12 | GABAergic synapse_Homo sapiens_hsa04727 | 2.44955242 |
13 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.44169152 |
14 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.27368905 |
15 | Protein export_Homo sapiens_hsa03060 | 2.24572155 |
16 | RNA polymerase_Homo sapiens_hsa03020 | 2.20970319 |
17 | Salivary secretion_Homo sapiens_hsa04970 | 2.18808490 |
18 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.13128144 |
19 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.99321229 |
20 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.96411690 |
21 | Taste transduction_Homo sapiens_hsa04742 | 1.95885182 |
22 | Insulin secretion_Homo sapiens_hsa04911 | 1.95867415 |
23 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.93385134 |
24 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.82176544 |
25 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.77043208 |
26 | Basal transcription factors_Homo sapiens_hsa03022 | 1.76420859 |
27 | Renin secretion_Homo sapiens_hsa04924 | 1.74581015 |
28 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.74165666 |
29 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.70840926 |
30 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.69493247 |
31 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.67945723 |
32 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.65446753 |
33 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.64136778 |
34 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.63307882 |
35 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.60222418 |
36 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.58750952 |
37 | Long-term depression_Homo sapiens_hsa04730 | 1.53525259 |
38 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.53298368 |
39 | Homologous recombination_Homo sapiens_hsa03440 | 1.52804091 |
40 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.47428854 |
41 | Alzheimers disease_Homo sapiens_hsa05010 | 1.44818919 |
42 | Proteasome_Homo sapiens_hsa03050 | 1.41485566 |
43 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.40989718 |
44 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.40168650 |
45 | Parkinsons disease_Homo sapiens_hsa05012 | 1.35724181 |
46 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.35697334 |
47 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.35109965 |
48 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.29292763 |
49 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.28786939 |
50 | Cocaine addiction_Homo sapiens_hsa05030 | 1.27575464 |
51 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.26389122 |
52 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.24843249 |
53 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.24593735 |
54 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.22158627 |
55 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.21219091 |
56 | Gap junction_Homo sapiens_hsa04540 | 1.16395860 |
57 | Phototransduction_Homo sapiens_hsa04744 | 1.16000524 |
58 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.11485547 |
59 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.09678022 |
60 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.07919941 |
61 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.07537853 |
62 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.05687681 |
63 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.04958959 |
64 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.04070434 |
65 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.03816373 |
66 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.03498080 |
67 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.02210802 |
68 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.00374366 |
69 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.99263286 |
70 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.98806501 |
71 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.97366230 |
72 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.96160907 |
73 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.95525507 |
74 | Purine metabolism_Homo sapiens_hsa00230 | 0.95305076 |
75 | Huntingtons disease_Homo sapiens_hsa05016 | 0.94216019 |
76 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.92626253 |
77 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.92589302 |
78 | Melanogenesis_Homo sapiens_hsa04916 | 0.88927725 |
79 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.88681626 |
80 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.88137601 |
81 | Glioma_Homo sapiens_hsa05214 | 0.87171393 |
82 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.84037657 |
83 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.82132065 |
84 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.81445235 |
85 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.80153506 |
86 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.78091100 |
87 | Axon guidance_Homo sapiens_hsa04360 | 0.77825872 |
88 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.77568080 |
89 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.76553533 |
90 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.76500381 |
91 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.76056270 |
92 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.76006460 |
93 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.75533546 |
94 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.75490971 |
95 | Ribosome_Homo sapiens_hsa03010 | 0.72323047 |
96 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.68558016 |
97 | Metabolic pathways_Homo sapiens_hsa01100 | 0.66730324 |
98 | Peroxisome_Homo sapiens_hsa04146 | 0.65484628 |
99 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.65111308 |
100 | Sulfur relay system_Homo sapiens_hsa04122 | 0.64737537 |
101 | Histidine metabolism_Homo sapiens_hsa00340 | 0.62622894 |
102 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.62394948 |
103 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.60965216 |
104 | RNA degradation_Homo sapiens_hsa03018 | 0.60442428 |
105 | RNA transport_Homo sapiens_hsa03013 | 0.58522739 |
106 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.58504344 |
107 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.54977324 |
108 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.54831942 |
109 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.54521025 |
110 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.54298003 |
111 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.53557205 |
112 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.51559375 |
113 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.51151781 |
114 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.49780298 |
115 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.49471835 |
116 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.48172759 |
117 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.47853403 |
118 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.46901018 |
119 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.46484610 |
120 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.45711103 |
121 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.44543578 |
122 | Mineral absorption_Homo sapiens_hsa04978 | 0.44105969 |
123 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.44067108 |
124 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.44008137 |
125 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.43962926 |
126 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.42139135 |
127 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.41698374 |
128 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.41677923 |
129 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.41322383 |
130 | Circadian rhythm_Homo sapiens_hsa04710 | 0.41013680 |
131 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.40981448 |
132 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.40691061 |
133 | Alcoholism_Homo sapiens_hsa05034 | 0.39951239 |
134 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.39944702 |
135 | Mismatch repair_Homo sapiens_hsa03430 | 0.39181460 |
136 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.39027050 |
137 | Phagosome_Homo sapiens_hsa04145 | 0.38110022 |
138 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.35737985 |
139 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.35402658 |
140 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.30486606 |
141 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.29782590 |
142 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.27329704 |
143 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.26766883 |
144 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.24384418 |
145 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.24330470 |
146 | Bile secretion_Homo sapiens_hsa04976 | 0.22588246 |
147 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.22444485 |
148 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.21930241 |
149 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.21491232 |
150 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.20753125 |
151 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.20529450 |
152 | Prion diseases_Homo sapiens_hsa05020 | 0.19355217 |
153 | Endocytosis_Homo sapiens_hsa04144 | 0.16407276 |
154 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.16243196 |
155 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.15220539 |
156 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.14758172 |